Insulin glargine, recombinant Subcutaneous and Phoslyra
Determining the interaction of Insulin glargine, recombinant Subcutaneous and Phoslyra and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: calcium acetate
Brand name: Calphron, Eliphos, PhosLo Gelcap, Phoslyra, PhosLo
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine, recombinant Subcutaneous-Phospha 250 Neutral
- Insulin glargine, recombinant Subcutaneous-Phosphasal
- Insulin glargine, recombinant Subcutaneous-Phospho-Soda Oral
- Insulin glargine, recombinant Subcutaneous-Phospholine Iodide
- Insulin glargine, recombinant Subcutaneous-Photofrin
- Insulin glargine, recombinant Subcutaneous-Phrenilin with Caffeine and Codeine
- Phoslyra-Insulin glulisine
- Phoslyra-Insulin Glulisine (Cartridges and Pens)
- Phoslyra-Insulin Glulisine (Vials)
- Phoslyra-Insulin glulisine Subcutaneous
- Phoslyra-Insulin human inhaled Inhalation
- Phoslyra-Insulin human regular Injection